A sad and sobering statistic. If you bought into an ASX200 fund three years ago your investment would be up over 11%.
In the same three years, an investment in SPL would have seen you lose almost 93% of your investment.
So the Chairman that has overseen the slow moving train wreck is still Chairman. And the recently retired and former long-serving Starpharma CEO is still an advisor to the Starpharma board.
Things work very strangely in the Starpharma parallel universe.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
-0.005(4.00%) |
Mkt cap ! $50.18M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.5¢ | 11.5¢ | $3.755K | 31.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 63402 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 106947 | 2 |
View Market Depth
| Last trade - 15.41pm 12/09/2025 (20 minute delay) ? |
| SPL (ASX) Chart |